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A key challenge in modern data analysis is understanding con-
nections between complex and differing modalities of data. For ex-
ample, two of the main approaches to the study of breast cancer are
histopathology (analyzing visual characteristics of tumors) and ge-
netics. While histopathology is the gold standard for diagnostics and
there have been many recent breakthroughs in genetics, there is little
overlap between these two fields. We aim to bridge this gap by devel-
oping methods based on Angle-based Joint and Individual Variation
Explained (AJIVE) to directly explore similarities and differences
between these two modalities. Our approach exploits Convolutional
Neural Networks (CNNs) as a powerful, automatic method for im-
age feature extraction to address some of the challenges presented by
statistical analysis of histopathology image data. CNNs raise issues
of interpretability that we address by developing novel methods to
explore visual modes of variation captured by statistical algorithms
(e.g. PCA or AJIVE) applied to CNN features. Our results provide
many interpretable connections and contrasts between histopathol-
ogy and genetics.
1. Introduction. The era of big data is marked not only by large datasets, but also complex
modalities of data such as images, networks, and text. A key challenge in the analysis of complex
data is data representation: what do you measure to capture the signal of interest (Marron and
Alonso, 2014)? Automated, data-driven methods for feature extraction have proven to be powerful
tools for analyzing complex data (Bengio, Courville and Vincent, 2013). This is particularly true for
predictive problems involving data modalities such as images and text where deep learning has made
major advances. Developing interpretable, data-driven feature extraction methods – particularly for
inferential analyses where the goal is for humans to learn about the underlying signal – is an ongoing
challenge (Doshi-Velez and Kim, 2017; Olah et al., 2018).
Modern scientific applications increasingly involve relating multiple modalities of data to one
another. The multi-block data setting1 means a fixed set of observations (e.g. patients) and several
sets of variables (e.g. gene expression, copy number, protein). The classical example of a multi-block
data algorithm is canonical correlation analysis (CCA) which, given two data blocks, estimates a
low dimensional joint signal capturing the information shared by the two blocks (Hotelling, 1936).
The multi-block data setting arises in recent cancer studies such as the Cancer Genome Atlas
(Network et al., 2012).
MSC 2010 subject classifications: Primary 62H35, 62P10
Keywords and phrases: Multi-view data, dimensionality reduction, image analysis, deep learning, interpretability,
breast cancer histopathology, gene expression
1This setting is also referred to as multi-view, multi-modal, or multi-omic data. Related terms include data fusion
and data integration.
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Two of the main approaches to the study of breast cancer are histopathology and genetics.
Pathologic assessment of breast tissue is the current state of the art method for breast cancer
diagnosis. A pathologist examines the tissue under a microscope in order to determine if there
is cancer as well as to assess important features used for determining the course of treatment
including histologic type, invasive status, tumor size, lymph node status, grade, as well as stain
for hormone receptors and HER2. Histopathology is the classical approach for diagnosing cancer
dating back to the 1800s (Rosen, 2001; Titford, 2006). Figure 1 shows an image of a hematoxylin and
eosin stained (H&E) breast cancer tumor from the dataset analyzed in this paper. Complementary
to histopathology, genetic information is increasingly used to understand the biological processes
underlying cancer. Genetics also plays an important role in tumor clustering/classification as well
as predicting patient prognosis and response to treatments (Gyo˝rffy et al., 2015).
Fig 1: A lower resolution view of a hematoxylin and eosin (H&E) stained 1mm core from a breast
cancer tissue microarray. The darker purple color (hematoxylin) stains nuclear material such as
DNA, while the pink (eosin) highlights structures such as connective tissue.
Most existing research in breast cancer focuses on a single data modality e.g. either histopathol-
ogy or genetics. For example, the development of automated algorithms to augment human pathol-
ogists’ judgements using machine learning is active area of research that aims to increase diagnostic
accuracy and decrease costs (Liu et al., 2017; Couture et al., 2018; Veta et al., 2019). Subtype dis-
covery (clustering) based on gene expression data is another major area of research (Perou et al.,
2000; Parker et al., 2009). Exploratory/inferential analyses, which study direct associations between
histopathology and genetics, are receiving increasing interest in recent years, but are hindered by
the challenge of doing inferential analysis on image data (Ash et al., 2018).
The Carolina Breast Cancer Study Phase 3 (CBCS) is a cohort of breast cancer survivors diag-
nosed between 2008 and 2013 and with both histologic and gene expression data (Troester et al.,
2017). CBCS provides a unique opportunity to explore both connections and differences between
genomics and histopathology that could lead to new discoveries e.g. improved classification. It is
known that genetics plays an important role in cancer development, so one might expect to see
joint modes of variation between the genetic and histopathological data. However, not all informa-
tion in one data modality is contained in the other, therefore, we expect to also see histopathology
individual as well as genetic individual modes of variation. To estimate these three different kinds
of signals, we use angle-based joint and individual variation explained (AJIVE) (Feng et al., 2018).
Statistical analysis of images presents difficulties for feature extraction. Convolutional neural
networks (CNNs) have proven adept at solving predictive tasks with images (Fukushima, 1980;
LeCun, Bengio and Hinton, 2015). Inspired by the approach in Couture et al. (2018), we use an
intermediate layer of a pre-trained neural network (see Section 2.2) for automatic image feature
extraction – so called transfer learning (Yosinski et al., 2014; Sharif Razavian et al., 2014). We
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explore the limits of transfer learning and show that pre-trained CNN features with no fine tuning
are able to capture complex visual signals in a domain vastly different than the one they were
originally trained for. See Section 5.0.2 for a longer discussion of transfer learning in the context
of this paper. While the use of CNNs allows us to capture rich visual information, it presents
difficulties because neural network features are notoriously difficult to interpret.
Leveraging deep learning for exploratory/inferential tasks, where the goal is to learn about
patterns in the data, presents new challenges and is an active area of investigation (Ash et al., 2018;
Adebayo et al., 2018; Olah et al., 2018). We develop a multi-scaled approach called representative
patch views (RPV) to interpret signals in the data captured by multivariate statistical algorithms2
applied to neural features (Section 3.1). This approach takes a patch-based representation of each
H&E image, allowing us to localize regions in each image that play an important role in a given
mode of variation. The RPVs operate at both the core level and patch level, providing a pathologist
with two different levels of granularity to explore the visual features associated with a particular
mode of variation.
Our AJIVE analysis is able to discover clear, interpretable, joint signals such as associations
between Basal-like (genetics) and high grade tumors (histology). The analysis also finds clear indi-
vidual signals in the histopathological data such as fat content and mucinous tumors.
Section 1.1 below discusses the results of the first AJIVE joint component which captures tumor
grade from the pathology perspective and the contrast between the Basal-like and Luminal A
PAM50 subtypes from the genetic perspective. Section 2 presents the data provided by CBCS as
well as the patch based, CNN image features extraction approach. Section 3 discusses the methods
used in this paper including the representative patch views and AJIVE. Section 4 interprets the
joint, image individual and genetic individual AJIVE components. Finally, Section 5 concludes with
more discussion about transfer learning and exploratory analysis with deep learning.
All correlations and AUC statistics reported in the text of the paper are statistically significant
at a level of 0.05 after controlling for multiple testing with the Benjamini-Hochberg procedure
Benjamini and Hochberg (1995) unless stated otherwise (see Section A.3).
The Appendix provides additional results and discussion. Section A.1 contains a brief description
of the tissue structures relevant to this paper. Section A.2 gives diagnostic plots for the AJIVE
analysis of the CBCS data. Section A.3 gives additional details of statistical analyses used in the
clinical data interpretation methods. The supplementary material includes a number of figures that
were excluded from the main body of the paper for brevity. In particular, all representative patch
views examined by pathologists are shown in Supplement A.
1.1. Results of the first AJIVE joint component. This section discusses the results of the first
AJIVE joint component; many of the technical details (e.g. the RPVs and multiple testing control)
are provided in Sections 2 and 3. In the CBCS dataset available to us there are n = 1191 subjects,
d1 = 50 genes (the PAM50 gene set) and d2 = 512 neural network features extracted from the
pathology images using a mean pool of the last convolutional layer of VGG16 (Simonyan and
Zisserman, 2014). To help interpret the results of the AJIVE analysis we use a variety of additional
variables that are provided by CBCS, but are not used in the AJIVE analysis. These include:
PAM50 molecular subtypes, histopathological variables (e.g. pathologist determined tumor grade),
immunohistochemical variables (e.g. estrogen receptor (ER) and clinical HER2 status), and patient
variables (e.g. age).
2Many statistical methods such as linear regression, PCA and AJIVE provide loadings vectors of neural features
(i.e. vectors in neural feature space) that don’t immediately tell us humans anything about the underlying biology.
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1.1.1. Methods overview. Like principal components analysis (PCA), AJIVE returns an (or-
dered) set of components comprised of scores vectors and loadings vectors (see Sections 3.2). While
PCA returns one set of components, AJIVE returns three sets of components when applied to two
data blocks: joint, block one (pathology) individual, and block two (genetic) individual. The joint
components capture joint signals shared between the two data blocks; the individual components
capture signals present in one data block that are not related to the other data block.
For interpretation purposes, we hypothesize that – like PCA components – each AJIVE com-
ponent discovers a spectrum contrasting interesting aspects of the data (e.g. Basal-like tumors vs.
non-Basal-like tumors). Interpreting the results of the AJIVE analysis often involves understanding
what biological phenomena are driving such a spectrum. One AJIVE component assigns a number
to each subject (the scores) and subjects can be sorted from most negative to most positive. In the
following analysis we consider the negative and positive extremes of each component.
By exploiting a patch based representation of the images, we can use the AJIVE neural network
loadings vectors to create the RPVs which are discussed in detail in Section 3.1 (see Figure 8).
Each RPV corresponds to a subject-component-end triple; one subject and one end of one AJIVE
component (e.g. subject 12 and the negative end of the first AJIVE joint component). The image
patches selected in the RPV are meant to be representative of the visual patterns characteristic
of an end of a component. For the sake of exposition, we primarily show a smaller version of the
RPVs in the body of the paper, which display only the top 8 patches (e.g. Figure 2).
1.1.2. Interpretation. We initially consider the negative and positive extremes of the first joint
component separately.
From the pathology perspective, two distinct visual patterns show up in the negative end of the
first joint component (Figures 2 and 3). Section A.1 has a brief explanation of the various tumor
structures which are relevant to this paper. The first pattern is dense tumor infiltrating lymphocytes
(TILs) and is illustrated in Figure 2 which shows the RPV of the most negative subject of the first
joint component. The smaller cells which have hyperchromatic round nuclei and relatively scant
cytoplasm (i.e dark, round, purple structures), are lymphocytes. In particular types of breast cancer,
TILs in the intratumoral stroma are associated with prognosis and may be associated with response
to immunomodulatory therapy (Wein et al., 2017).
Fig 2: Several representative patches from the most negative subject of joint component 1. The
dark, round, purple structures are lymphocyte nuclei; these patches show dense tumor infiltrating
lymphocytes which are characteristic of high central grade tumors. The third images in both rows
show a significant number of tumor cells, mixed with some lymphocytes. This tumor is a genetically
Basal-like tumor like most of the other tumors on the negative end of this component (Figure 5b).
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The second visual pattern in the negative end of the first joint component is dense, high nuclear
grade tumor cells and is illustrated in Figure 3. Nuclear grade describes how abnormal the tumor
cells look: “low grade” means the tumor cells look similar to regular cells (“well-differentiated”)
and “high grade” means the tumor cells look markedly abnormal (“poorly-differentiated”) e.g. are
enlarged and irregularly shaped (Rosen, 2001).
On the positive end of the first joint component, the pathology review shows subjects whose cores
contain mostly normal breast tissue i.e. little tumor tissue. This pattern is illustrated by Figure 4,
which shows the subject with the most positive scores for the first joint component. These patches
contain few tumor cells and are mostly normal breast structures such as collagenous stroma (the
light pink, stringy tissue) and ducts.
Fig 3: The third most negative subject from joint component 1. The patches selected for the RPV
of this tumor show high nuclear grade cells which are large and irregularly shaped. These are also
characteristic of high grade tumors. This tumor is also genetically Basal-like.
Fig 4: The subject with the most positive scores. These RPV patches are comprised primarily of
normal breast tissue and contain few tumor cells. The eosinophilic, fibrillar (light pink, stringy)
tissue is collagenous stroma which is found in normal breast tissue while the white circles surrounded
by purple dots are neoplastic ducts. This tumor is genetically Luminal A.
The first joint component is related to histopathological features including tumor grade and
histological type (ductal vs. lobular). For example, Figure 5a shows that high grade tumors cluster
on the negative end of the first joint component while low grade tumors cluster on the positive end
(AUC = 0.945). Tumor grade incorporates cellular differentiation and other architectural features
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as an indicator of aggressiveness (Elston and Ellis, 2002). This first component is also statistically
significantly related to histological type with ductal on the negative end and lobular on the positive
end (AUC = 0.785).
(a) Tumors on the negative end
tend to be high grade while those
on positive end tend to be low
grade.
(b) The Basal-like class is on the
negative end of the scores, the
HER2/Luminal B classes are in the
middle and the Normal/Luminal A
classes are on the positive end.
(c) Proliferation score is strongly
associated with the common nor-
malized scores with a Pearson cor-
relation of -0.82.
Fig 5: Joint component 1 scores vs. PAM50 molecular subtype (5b), central grade (5a) and prolif-
eration score (5c). The x-axis in each plot shows the subjects’ common normalized scores. These
figures tell a complementary story. For example, Basal-like tumors tend to be more aggressive, high
grade and have a high proliferation score.
Fig 6: PAM50 loadings vector from joint component 1. Several of the top negative genes are asso-
ciated with high tumor cellularity and typically have low expression levels in normal breast tissue
(consistent with Figures 3 and 2). Several of the top positive genes tend to have high expression
levels in normal breast tissue (consistent with Figure 4).
From the genetics perspective, the first joint component strongly tracks the proliferation score
as well as the contrast between Basal-like vs. Luminal A tumors. Figure 6 shows the PAM50 joint
loadings vector for the first component. Several of the top negative genes (e.g. CCNB1, CENPF,
MYC, MKI67) are associated with high tumor cell proliferation and tend to have low expression
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levels in normal breast tissue. Several of the top positive genes (e.g. MLPH, MMP11) tend to
have high expression levels in normal breast tissue. Note that FOXC1 is highly expressed in both
basal-like and normal-like breast myoepithelium.
Figure 5b shows that Basal-like tumors cluster on the negative end of the first joint component,
molecular HER2 and Luminal B cluster in the middle while Luminal A and normal tumors cluster on
the positive end. Note the AUC score for Basal-like vs. Lum A is 0.984 which is quite high. Luminal
B and molecular HER2 are separated from Basal-like (AUCs of 0.886 and 0.876). The separation
indicates that this joint component is distinguishing more subtle histopathological and molecular
features beyond proliferation and cellularity. Figure 5c shows a strong, negative correlation between
the first joint component scores and the proliferation score, which is a genetic measure indicative
of how fast tumor cells grow (Whitfield et al., 2002).
Strikingly, the first joint component almost perfectly separates ROR-PT, which is a combined
genetic and pathology based risk of recurrence score Parker et al. (2009). Patients with high ROR-
PT are clustered on the negative end while patients with a low ROR-PT are clustered on the
positive end with an AUC of 0.999.
In addition to genetic phenotypes measured by RNA expression data as just discussed, we also
have immunohistochemistry (IHC) data, a surrogate measure of RNA subtypes and the most com-
mon way of classifying tumors in a clinical setting. From the IHC perspective, the first joint com-
ponent is strongly related to ER status and weakly related to clinical HER2 status (see Table 2).
Clinical ER negative tumors cluster on the negative end of this component with an AUC of 0.883.
In this first joint component, the pathology and genetics tell complementary stories that are
familiar to breast cancer experts. The data raise the possibility that this joint component separates
tumors based on one or more histologic features associated with tumor grade. These features could
include aspects of nuclear atypia (i.e increased nuclear size, irregular shape, altered chromatin
pattern, multiple nucleoli) which are reflected in the nuclear grade. Tumors with a high combined
histologic grade also tend to be more cellular and show less tubule or gland formation as compared
to low-grade tumors.
From the genetics perspective, Basal-like tumors are on the negative end, molecular HER2/Luminal
B tumors are in the middle, and Luminal A/Normal like tumors are on the positive end. The joint
scores are strongly negatively correlated with the proliferation score. The negative genes in Figure 6
are predominantly proliferation regulated genes; however, we note several of the positive genes are
often considered basal-specific genes. These genes are also expressed in normal myoepthelieum and
are representative of the normal ducts still observed within slides of the low grade tumors (Livasy
et al., 2006; Heng et al., 2017).
Aggressive tumors tend to have high tumor cellularity and little benign tissue. In less aggressive
tumors, there is typically more normal breast tissue. Basal-like tumors tend to be more aggressive
and are generally associated with high tumor grade, ER negativity, ductal histology, and high
proliferation score (Livasy et al., 2006; Troester et al., 2017; Williams et al., 2019). Luminal B and
molecular HER2 tumors tend to be moderately aggressive. Luminal A and Normal like tumors are
less aggressive and it is known these tend to be low grade.
It is promising that this mode of variation turned up in the first joint component. These connec-
tions between the underlying genetic drivers and the pathological impressions have both geneticists
and pathologists excited about the potential of AJIVE to quantitatively integrate these different
aspects of cancer.
1.2. Related literature. There is a large literature on dimensionality reduction for multi-block
data including classical algorithms such as CCA Hotelling (1936) and partial least squares Wold
(1985) as well as more modern methods such as: multi-block versions of CCA Kettenring (1971);
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Nielsen (2002); Asendorf (2015), iNFM Yang and Michailidis (2015), SLIDE Gaynanova and Li
(2017) and BASS (Zhao et al., 2014). JIVE Lock et al. (2013) and AJIVE Feng et al. (2018) are
some of the first methods to look at both joint as well as individual modes of variation.
Interpretability in deep learning is a growing field (Vellido, Mart´ın-Guerrero and Lisboa, 2012;
Molnar et al., 2018; Chen et al., 2018a; Kim et al., 2018; Olah et al., 2018; Holzinger et al., 2019).
Saliency maps interpretation methods involve visualizing the gradient (or a related quantity) of
the output of a CNN with respect to a given input image (Zeiler and Fergus, 2014; Springenberg
et al., 2014; Selvaraju et al., 2017; Sundararajan, Taly and Yan, 2017; Adebayo et al., 2018). We
adapted several of these methods for the AJIVE analysis and explored their applicability to our
data; unfortunately, none of the methods provided consistently interpretable outputs and raised
issues which will be explored in a follow up paper.
Deep learning based predictive analysis of histological images is a growing area (Komura and
Ishikawa, 2018; Aeffner et al., 2019; Niazi, Parwani and Gurcan, 2019; Abels et al., 2019) which
includes tasks such as classification/regression (Wang et al., 2016; Liu et al., 2017; Bejnordi et al.,
2018; Ilse, Tomczak and Welling, 2018; Liu et al., 2018; Veta et al., 2019), semantic segmentation
Jime´nez and Racoceanu (2019); Mahmood et al. (2019), and microscope augmentation (Chen et al.,
2018b) CNN architectures which integrate genetic (or other) information are also being explored for
these predictive tasks (Couture et al., 2018; Srivastava et al., 2018; Mahmood et al., 2018). Other
studies used non-deep learning based methods to do exploratory, integrative analysis of histological
and genetic data Beck et al. (2011); Wang et al. (2013); Cooper et al. (2015)
A similar joint, exploratory analysis of breast cancer H&E image and gene expression data was
performed by (Ash et al., 2018). Our methods differ from theirs in a number of ways: they only
examined joint signals while we examine both joint and individual signals; they used a sparse CCA
while we use AJIVE; we develop and use the RPVs for image interpretation; they trained an auto-
encoder while we use transfer learning. An important result of our paper is that even simple transfer
learning effectively captures the important signals in the data.
1.3. Software and data release. The code to reproduce the analysis in this paper can be found
at github.com/idc9/breast_cancer_image_analysis. The raw data e.g. H&E images, gene ex-
pression data, clinical variables cannot be released publicly due to patient confidentiality con-
cerns. Researchers may request permission to access the raw data used in this study by visiting
https://unclineberger.org/cbcs/for-researchers/.
The scikit-image library is used for various image processing tasks (Van der Walt et al., 2014).
The PyTorch framework is used for all neural network computations (Paszke et al., 2017). The
pre-trained VGG16 weights are downloaded with the PyTorch vision library. We used many of the
standard python data science libraries e.g. NumPy Van Der Walt, Colbert and Varoquaux (2011),
SciPy Jones, Oliphant and Peterson (2014), sklearn Pedregosa et al. (2011), pandas McKinney
(2011), Matplotlib Hunter (2007), and seaborn Waskom et al. (2018). AJIVE computations are
done with the py jive package Carmichael (2019) which was developed for this project.
2. Data.
2.1. CBCS. The data came from the Carolina Breast Cancer Study, a population-based study of
black and white women with invasive breast cancer diagnosed between 2008-2013 in North Carolina.
Tumor blocks were collected and cores were transferred from the donor paraffin blocks to prepare
tissue microarrays as well as to isolate RNA for gene expression analysis. Tissue preparation and
molecular methods are described in (Troester et al., 2017; Allott et al., 2018). The current analysis
includes n = 1191 patients for whom both image and gene expression data were available.
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For each patient, a pathologist reviewed a paraffin-embedded tumor block and marked the area
containing the invasive carcinoma. Then a lab technician extracted a number of circular “cores”,
which were then transferred into a recipient TMA paraffin block and eosin (H&E) and imaged.
Supplement A shows a graphical depiction of this process. The upshot is that for each patient we
have a median3 of 4 H&E stained core images. The images of these cores are roughly circular with
an average width of approximately 2500 pixels4. An example core image is shown in Figure 1. It is
appealing to work with cores and not the much larger whole slide images because the cores provide
more concentrated tumor cells and are more computationally tractable5.
Pathologic evaluation of the tumor (including histologic type and grade) was based on the original
whole tissue sections. We also compute a number of variables describing image features such as the
proportion of white background and the median intensity of the background pixels.
For each patient, we have the PAM50 gene expression measurements, which are 50 genes chosen
to distinguish the 5 clinically relevant, genetic subtypes (Basal-like, Luminal A, Luminal B, molec-
ular HER2 and Normal-like) (Parker et al., 2009). The intrinsic subtype gene list was developed
using genes which were consistently expressed within the tumor while minimizing the contribution
of the non-tumor microenvironment; therefore the PAM50 genes do not describe the tumor mi-
croenvironment (Perou et al., 2000). We also have a number of variables derived from the PAM50
gene expression such as proliferation score and ROR-PT (Parker et al., 2009). The ROR-PT is a
risk of recurrence score based on both genetic and histological information (e.g. tumor size).
CBCS provides clinically relevant immunohistochemical variables (ER status, clinical HER2
status and PR status), which are derived from routine methods used in the clinical laboratory.
Finally, there are other patient variables such as age which are discussed in Supplement A.
The 50 gene expression variables under go pre-precessing which includes centering and scaling
by their standard deviation resulting in the gene expression data matrix Xgenes ∈ R1,191×50.
2.2. Image processing and patch representation. In order to achieve uniform visual stain density,
the raw H&E core images are stain normalized using the procedure described in (Macenko et al.,
2009). The set of background pixels of each image (i.e. the whitespace in Figure 1) is then estimated
via the following procedure. Each image is converted to grayscale, then a background pixel intensity
threshold is estimated with weighted6 combination of (0.1) Otsu’s method Otsu (1979) and (0.9)
the triangle method Zack, Rogers and Latt (1977). The background mask (True/False array saying
whether or not a pixel is in the background) is then used for a variety of downstream tasks. For
example, using the background mask we can estimate the channel wise median background pixel
and compute the proportion of background in the entire image.
Next we create a patch-based representation of each image. Each core image is broken into a grid
of 200 × 200 pixel patches. To make an even grid of patches, the image is first padded with the
estimated typical background pixel so its dimensions are divisible by 200. Using the background
mask, patches which are more than 90% background are thrown out (Figures 7a and 7b). The
background threshold (90%) was selected via manual inspection to be the smallest value such that
patches with large amounts of fat and some tissue are still included (Figure 7b).
There are a total of 5, 970 core images from the 1, 191 subjects resulting in 761, 767 patches. We
estimate the channel (red, green, blue values for each pixel) mean and standard deviation from the
3Minimum of 1 and maximum of 8.
4Min 600, max 3400.
5The whole slide images can be of order 50,000 × 50,000 pixels or larger.
6Through exploratory analysis we noticed that off the shelf methods (e.g. Otsu alone) had systemic issues with
images which have a high proportion of background (e.g. those with a high fat content or high mucin content). This
particular combination was selected by tuning on a visual examination of the 100 images with the highest proportion
background.
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patch dataset. Before being input into the neural network, each pixel channel is mean centered then
scaled by the standard deviation.
(a) The patch grid for an example core. (b) A core with high fat content.
Fig 7: Patch grid for two example cores, one with low fat content (a) and one with high fat content
(b). Black squares indicate patches with too much background that were excluded. The background
threshold is selected such that the thin pieces of tissue surrounding fat cells (and other structures
with lots of white space such as mucin) are included.
2.3. CNN feature extraction. After the raw images are processed, CNN features are extracted
from each patch. We use the last convolutional layer of the VGG16 architecture Simonyan and
Zisserman (2014) with an additional spatial mean pooling layer added to the end of this architecture
to average out spatial information resulting in 512 CNN features. In other words, if the output from
the original network applied to a 200× 200× 3 pixel image is sized H ×W × 512 (where 512 is the
depth), the spatial mean pool will output a 512 dimensional vector. The pre-trained weights of the
network are downloaded from the torch vision library. No additional fine-tuning is performed (see
Section 5.0.2 for discussion).
Finally, core-images are represented as an average of their patch features (again, ignoring patches
which are over 90% background). Patients are then represented by an average of their cores. Supple-
ment A provides a graphical representation of this process. Each CNN feature is first mean centered
then scaled by its standard deviation resulting in the image feature data matrix X image ∈ R1,191×512.
3. Methods. A key challenge for doing statistical inference on populations of images with deep
learning is interpretability. In section 3.1 we explain the novel, broadly applicable RPV method
for interpretation of the visual signals captured by neural network features. In Section 3.2 we
give an overview of the AJIVE procedure. Section 3.3 describes the pathology review process for
interpreting the AJIVE image modes of variation.
3.1. Representative patch views. The RPV assumes that images7 are represented via the patch
based approach described in Sections 2.2 and 2.3. In other words, images are broken into a collection
of patches; CNN features are extracted for each patch then images are represented as an average of
their patch features. Suppose we compute a loadings vector of image features (e.g. the first image
PCA component). The RPV illustrates one end of a loadings vector (e.g. the positive end of PC 1).
For each end of one component, we select the top 15 subjects (e.g. the subjects with the 15 most
positive PC scores) then create the RPVs for each of these subjects.
Figure 8 shows an example RPV displaying one subject for the negative end of AJIVE joint
component 1. The leftmost column shows the four cores for this subject. The rightmost five columns
7In the CBCS study each subject has a number of core-images and subjects are represented as an average of their
images. For exposition purposes we pretend each subject has one image in this section, however, the extension to the
multi-image case is clear.
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show the top 20 patches for the negative end of the first joint component from the patch based
localization approach described below in Section 3.1.1. The second column shows the location on
each core of the top 20 patches. The RPVs are multi-scale in the sense that they give insights at
both the core level and the patch level.
Fig 8: The full representative patch view from Figure 3. The first column shows the 4 cores for this
subject (high resolution is needed to see detail). The 20 patches (Section 3.1.1) in the last 5 columns
are representative of the visual features associated with one extreme of a mode of variation. The
second column shows the patches’ locations on the cores. Lymphocytes show up prominently in
these patches. Some images (1, 8, 11, 18) show predominantly tumor cells, and others (10, 14, 15)
show a roughly even mixture of lymphocytes and tumor cells.
3.1.1. Patch based localization. Here we describe the general approach used to select the rep-
resentative patches for the RPVs described in the above section. Patch based localization is ac-
complished by projecting patches onto the loadings vector. Main ideas are illustrated below in the
context of PCA but this approach is quite general.
Let n be the number of subjects (images) in the dataset, mi be the number of patches for the
ith image, pij be the jth patch for the ith subject, f : image→ Rk the feature extraction network
outputting k features. Also let zij := f(pij) be the features for patch pij , zi :=
1
mi
∑mi
j=1 zij be the
average patch features for the ith subject, Z ∈ Rn×k be the image feature dataset, and Z˜ ∈ Rn×k be
Z after processing (e.g. centering and scaling). Let v ∈ Rk be a loadings vector and u = Z˜v ∈ Rn
the scores vector8 computed from Z˜ (e.g. PC component 1).
Consider the positive end of this component and let i∗ be the index of a particular image. We
perform patch based localization9 by projecting every patch of subject i∗ onto v. In detail, let z˜i∗,j
8We assume that the scores are the projection of the data onto the loadings vector.
9We use the term localization because this method helps identify which regions in the image are playing an
important role in the given mode of variation.
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be the features of the jth patch for subject i∗ after the processing. Let si∗,j := z˜Ti∗,jv be the scores
of this patch for j = 1, . . . ,mi∗ . Now let j(1), . . . , j(20) be the indices of the patches with the 20
most positive patch scores (i.e. si∗,j(1) ≥ si∗,j(2) . . . ). We call these the representative patches for
the positive end of this component.
Principal components analysis can be viewed as finding important modes of variation in the
data. If we used “interpretable” features, then inspecting the top entries of the loadings vector, v,
would shed light on what this given mode of variation is about. Unfortunately, for uninterpretable
features such as abstract neural features, inspection of a loadings vector does not provide much
interpretable information. Note this visualization procedure can be applied to statistical algorithms
other than PCA; it simply requires an algorithm that outputs loadings vectors of neural features.
3.2. Angle-based joint and individual variation explained. Angle based joint and individual vari-
ation explained (AJIVE) is a statistical feature extraction/dimensionality reduction algorithm for
multi-block data (Feng et al., 2018). The goal of AJIVE is to find joint signals, if any exist, which
are common to all data blocks as well as individual signals which are specific to each block, if they
exist. Here we give a brief overview of AJIVE for two data blocks.
Consider two data blocks X ∈ Rn×dx , Y ∈ Rn×dy on the same set of n observations. AJIVE
estimates what variation is joint to both data blocks as well as what variation is individual to each
block. In particular, each matrix is decomposed into a sum of joint, individual, and error terms,
X = Jx + Ix + Ex and Y = Jy + Iy + Ey
while imposing the following constraints
• col-span(Jx) = col-span(Jy) := J ⊆ Rn
• col-span(Jx) ⊥ col-span(Ix) and col-span(Jy) ⊥ col-span(Iy)
• col-span(Ix) ∩ col-span(Iy) = ∅
All subspaces live in Rn where n is the number of observations. The two joint matrices span the
same joint subspace, J . The two individual matrices span subspaces which are orthogonal to the
joint subspace. We refer to the rank of the joint subspace as the joint rank, RJ , and the rank of
the two individual subspaces as the X and Y individual ranks, Rx, Ry.
The mechanics of AJIVE are outlined below for the case of B = 2 data blocks10. The properties
of the common normalized scores discussed below follow from the fact they are the subspace flag
mean of the PCA scores subspaces Draper et al. (2014). We use a different estimate of the block
common loadings, Lx, Ly than in the original paper. One of the key statistical procedures in AJIVE
is to estimate the joint rank11 which is achieved using the Wedin bound and the random direction
bound detailed in (Feng et al., 2018).
1. Initial signal extraction: Estimate low rank PCAs of X,Y with ranks rxinit, r
y
init (e.g. se-
lected by inspecting the PCA scree plots). Denote this initial PCA of X by Uxinit, D
x
init, V
x
init
where Uxinit ∈ Rn×r
x
init , V xinit ∈ Rdb×r
x
init . Similarly for y.
2. Signal space extraction: Perform CCA on the PCA scores, Uxinit, U
y
init. Using the random
direction bound and the Wedin bound estimate the CCA rank, RJ . Let S
x, Sy ∈ Rn×RJ be the
matrices whose columns are the x/y CCA scores with unit norm. Let W x ∈ Rrxinit×RJ ,W y ∈
Rr
y
init×RJ be the matrices whose columns are the CCA x/y loadings. Let C ∈ Rn×RJ be the
common normalized scores which have the property of being proportional to the average of
10The original paper describes the procedure some what differently, but this description is equivalent.
11This is accomplished by estimating which principal angles between col-span(Uxinit)and col-span(U
y
init) are smaller
than random in an appropriate sense.
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the x/y CCA scores. In other words, the jth column of C is unit norm and is proportional to
the average of the jth columns of Sx and Sy. Additionally the common normalized scores are
orthonormal i.e. CTC = IRJ . Finally, let
12 Lx := V xinitD
x−1
initW
x ∈ Rdx×RJ be the x-common
loadings. Similarly for y.
3. Signal space extraction: Let Jx := CCTX be the estimated joint matrix. Let I˜x :=
(I − CCT )X ∈ Rn×dx . Let Rx be the number of singular values of I˜x above the threshold
discussed in Section 2.4 of Feng et al. (2018) and let Ix ∈ Rn×dx be the rank Rx SVD
approximation of I˜x. We denote the PCA of the individual matrix Ix by Uxindividual ∈ Rn×Rx ,
Dxindividual ∈ RRx×Rx , V xindividual ∈ Rdx×Rx which is also of interest. Similarly for y.
The outputs of interest in this paper are the following
• The joint rank, RJ .
• The common normalized scores, C ∈ Rn×RJ .
• The common loadings13, Lx ∈ Rdx×RJ , Ly ∈ Rdy×RJ .
• The Uxindividual ∈ Rn×Rx and V xindividual ∈ Rdx×Rx , which are referred to as the block specific,
individual scores and loadings. Similarly for y.
The common loadings, Lx, Ly are different than those in (Feng et al., 2018). The loadings com-
puted here are the loadings such that XLx + Y Ly ∝ C i.e. the average of the resulting scores are
proportional to the common normalized scores. Computing the loadings in this way ensures that
they incorporate joint information only.
Remark 3.1. It can be checked that the random direction bound is equivalent to the classical
Roy’s largest root test CCA rank selection method (Johnstone, 2008).
3.2.1. AJIVE analysis of CBCS data. The only variables used in the AJIVE analysis are the
512 CNN image features and expressions for 50 genes from PAM50; the other variables are used
to interpret the AJIVE results. The initial signal ranks are 81 (image features) and 30 (genes) and
were selected by inspection of the difference of the log-singular values and airing on the side of
picking too high a rank. AJIVE estimates a joint rank of 7, image individual rank of 76 and genetic
individual rank of 25. The AJIVE diagnostic plot, detailed in Feng et al. (2018), is provided in A.2.
3.3. Pathology review of images. In close collaboration with pathologists (B.C. and J.G.), we
reviewed the first three joint and image individual components at two levels of granularity. Tables
1 and 3 summarize the pathologists’ observations of these components. These observations are key
to understanding the connections between the pathology and the genetics.
In the first approach, which we refer to as global sort, all core images are reviewed in sequence
after sorting by the patient scores. Joint components are sorted by common normalized scores, C,
and individual components are sorted by block specific scores, U imageindividual (see Section 3.2). After
sorting, the images are reviewed in sequence (e.g. from the negative to the positive end) to explore
the visual signals captured by a given component. The benefits of the global sort method are i)
a large number of images are inspected ii) we get a sense of the high level changes14 as we move
along a component from the extreme negative to the middle then to the extreme positive end and
12Note the jth column of V x is equivalent to the rank rxinit principal components regression coefficient of the jth
column of the common normalized scores, C, regressed on the X matrix.
13These were not given names in the Feng et al. (2018) and were computed slightly differently.
14In a preliminary analysis where image patches with a large amount of background were not excluded (see Section
2.2), the global sort method on the first few principal components revealed that the primary modes of variation in the
data are driven by the raw amount of background. This motivated the exclusion of patches with too much background.
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iii) we can see if the trends found in the RPVs (see next paragraph) hold broadly for the entire
component. The downsides of this method are that it is time intensive and does not provide explicit
information about what visual signals are important in a given image. The H&E images are quite
large and complex and finding patterns across a set of images is challenging.
The RPV approach developed in Section 3.1 extracts more fine-grained information at the patient
level. The RPVs of the 15 most negative and 15 most positive subjects are inspected for each
component. The RPVs are created with the common loadings Limage for the joint components and
the block specific individual loadings V imageindividual (see Section 3.2). The number 15 was selected to
balance showing “enough” information without taking too much time. The RPVs have the benefit
of highlighting a more focused set of visual patterns.
Tables 1 and 3 display the pathologist’s observations based on the RPVs at each end of each
component. Each column summarizes the pathologist’s impression of a clinically relevant histolog-
ical feature. The homogeneous column indicates whether or not there appeared to be a consistent
pattern across the reviewed RPVs. The global sort review shows these trends hold for more than
just the 15 most extreme images.
4. Results. This section discusses the results for the joint AJIVE components (Section 4.1),
the image individual (Section 4.2) and genetic individual (Section 4.3). For the sake of time – both
the readers’ and the pathologists’ – we focus on the top 3 components from each of the joint, image
individual and genetic individual.
The pathology review of the images from the joint and image individual components is described
in Section 3.3. While the pathologist reviewed the full RPVs (Figure 8), only mini-RPVs (e.g. Figure
9a) displaying 8 patches are shown below. The full RPVs shown to the pathologists, all AJIVE
genetic loadings, and all clinical data comparisons are provided in Supplement A. The methodology
for clinical data comparisons (e.g. multiple testing control) is discussed in Section A.3.
4.1. Joint image and genetic information. Table 1 summarizes the pathologist’s observations
based on the RPVs of the first three joint components. Component 1 was discussed in Section 1.1.
component end homogeneous
tumor
cellularity
tubule
formation
nuclear
grade
adipocytic
stroma
collagenous
stroma
lymphocytes necrosis
1 positive no low yes 1, 2 yes yes no no
negative yes high no 3 no limited yes yes
2 positive no variable yes 3 focal yes few no
negative yes moderate/high yes 2 focal yes no no
3 positive no variable yes 3 yes limited yes no
negative yes moderate/high no 3 no yes no no
Table 1
A pathologist’s summary of important clinical features based on the RPVs of the 15 most extreme subjects for each
end of the first three joint components. The “homogeneous” column indicates whether or not the patterns shown in
the RPVs were consistent across the 15 subjects.
Component ER status Clinical HER2 status
1 0.883 (+) 0.558
2 0.752 (−) 0.617 (+)
3 0.551 0.777 (−)
Table 2
AUC scores for two immunohistochemical (IHC) variables, ER status and clinical HER2 status (positive vs. negative
classes), for first three joint components based on AJIVE common normalized scores. All six of of these comparisons
are statistically significant. The sign in parentheses indicates which end of the component the IHC positive status
cluster on if there was a clear visual separation in the histogram (see Supplement A). For example, ER status
positive tumors cluster on the positive end of component 1.
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4.1.1. Joint component 2. From the pathology perspective, the tumors on the negative end of
joint component 2 show mostly collagenous stroma surrounded by moderate nuclear grade tumor
cells. Figure 9 shows the mini-RPVs of two subjects from the negative end of the second joint
component. The positive end of this component was not homogeneous (Table 1).
(a) (b)
Fig 9: Two tumors from the negative end of joint component 2. Both RPVs show collagenous stroma
(light pink, stringy tissue) surrounded by moderate nuclear grade tumor cells and moderate tumor
cellularity. The tumor in (a) is genetically Luminal B and the tumor in (b) is Luminal A.
(a) Joint component 2, PAM50 loadings. (b) Joint component 2 scores conditioned on PAM50 subtype.
Fig 10: The Luminal B and Luminal A classes are associated with the negative end of joint com-
ponent 2. Not much is known about this histology of Luminal cancers.
From the genetics perspective, the negative end of joint component 2 picks out the Luminal
B subtype (Figure 10b). Looking at the PAM50 loadings vector, ESR1, SLC39A6 are the two
most negative genes in the PAM50 loadings (Figure 10a) and are known to be high in clinically
ER+ cancers (Parker et al., 2009). The Luminal B observations cluster on the negative end of
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this direction and are statistical significantly separated from the other PAM50 subtypes with AUC
scores of: Basal = 0.905, HER2 = 0.933, Luminal A = 0.760, Normal = 0.950 (Figure 10b).
From the immunohistochemical perspective, the second joint component is moderately related
to ER status while weakly related to clinical HER2 status (Table 2). Clinical ER positive tumors
cluster on the negative end of this component with an AUC of 0.752.
The pathology perspective of this second joint component appears to pick up on morphological
features of Luminal B tumors i.e. intratumoral channels of stromal cells which are surrounded
by moderate nuclear grade cancer cells. To our knowledge, little is known about the histological
features of Luminal B tumors. Interestingly, Beck et al. (2011) used image analysis approaches
to demonstrate connections between certain stroma morphological features and patient survival.
Pathologists do not currently use stromal features in the diagnosis and classification of tumors.
However, tumor stroma and microenvironment (Eiro et al., 2019) and the stromal features of
benign and tumor-adjacent normal tissue (Roma´n-Pe´rez et al., 2012; Chollet-Hinton et al., 2018)
are areas of active investigation. Recent studies using CNNs have shown that breast biopsies may
be accurately classified as malignant solely based on stromal features (Bejnordi et al., 2018).
(a) Joint component 3, PAM50 loadings. (b) Joint component 3 scores conditioned on PAM50 subtype.
Fig 11: The molecular HER2 subtype are associated with the negative end of joint component 3.
4.1.2. Joint component 3. From the genetics perspective, the negative end of joint component 3
picks out molecular HER2. The HER2 observations are separated from the other PAM50 subtypes
with AUC scores of: Basal = 0.947, Luminal A = 0.940, Luminal B= 0.833, Normal = 0.950.
Interestingly, ERBB2 and EGFR have large negative values in the joint loadings vector while
GRB7, which is on the same amplicon as ERBB2, is almost 0 (Figure 11a). The negative end of this
component is also moderately related to clinical HER2 status with an AUC of 0.777 (Table 2). This
component is identifying not only clinical HER2 samples (as determined by IHC staining) but more
strongly the molecular HER2 subtype of samples (as determined by gene expression). Previous work
(Network et al., 2012) has shown both gene expression and protein and phosphoprotein levels of
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ERBB2 and EGFR are significantly enriched in clinically HER2 samples that are also the molecular
HER2 subtype compared to clinical HER2 samples that are Luminal subtypes. This is consistent
with the separations we see in joint component 3.
From the pathology perspective, the negative end joint component 3 again shows collagenous
stroma, but this time surrounded by high nuclear grade tumor cells (Figure 12). Recall joint com-
ponent 2 was similar but with moderate grade tumor cells. This third joint component appears to
be picking up on morphological features of molecular HER2 tumors. Similar to joint component 2,
it is interesting that the stroma appear to play an important role in this component.
(a) (b)
Fig 12: Tumors from the negative end of joint component 3 showing tumor cells surrounded col-
lagenous stroma.
4.2. Image individual information. As mentioned in Section 2.1, the PAM50 genes were selected
to emphasize genes expressed in tumor epithelium, not genes highly expressed in tumor microen-
vironment features such as fat cells, collagenous stroma, and in some cases mucin. Several of these
microenvironment features have clear visual signals (e.g. high fat content images have round, clear
adipose cells) and show up prominently in the AJIVE individual components.
component end homogeneous
tumor
cellularity
tubule
formation
nuclear
grade
adipocytic
stroma
collagenous
stroma
lymphocytes necrosis
1 positive yes low focal 1, 2 yes limited few no
negative yes variable no 2 no yes few some
2 positive yes moderate no 2, 3 focal yes yes no
negative yes low no 1 focal limited no no
3 positive yes low yes 2 focal yes few no
negative yes low no 2 yes no no no
Table 3
A pathologist’s observations of first three image individual components from RPVs of 15 most extreme subjects on
either end of the component.
4.2.1. Image individual component 1. All of the images on the positive end of the first image
individual component shows a very clear theme of tumors with high fat content (Figure 13). High
fat content is a strong visual signal so it makes sense that it shows up as an early individual mode
of variation for image data. The negative end of the first image individual component shows tumors
with low tumor cellularity and low/moderate grade nuclei (Table 3 and Figure 14).
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(a) (b)
Fig 13: Two tumors from the positive end of image individual component 1 showing high fat content.
(a) (b)
Fig 14: Two tumors from the negative end of image individual component 1 showing moderate
nuclear grade, variable tumor cellularity, collagenous stroma.
4.2.2. Image individual component 2. The negative end of image individual component 2 clearly
picks out mucinous carcinoma tumors (Figure 15). Mucinous carcinomas are characterized by tumor
cells floating in pools of mucin. These cancers presents a very clear visual pattern of dark purple
tumor cells surrounded by wispy looking mucin. Mucinous carcinoma is a rare histological subtype
which the PAM50 genes Perou et al. (2000) are not designed to identify.
Mucinous carcinomas are typically low-grade, hormone receptor-positive, have a good prognosis
and appear to be genetically different from invasive ductal carcinomas of no special type (Diab
et al., 1999; Di Saverio, Gutierrez and Avisar, 2008; Weigelt et al., 2009; Lacroix-Triki et al., 2010).
Mucinous carcinomas are usually genetically Luminal-type (typically Luminal A) (Colleoni et al.,
2011; Caldarella et al., 2013; Weigelt et al., 2009). All of the top 15 tumors on the negative end of this
component are genetically Luminal (12 are Luminal A and 3 are Luminal B). Interestingly, neither
the Luminal A nor B classes are strongly associated with the individual scores for this component
overall; none of the difference in distribution tests (Section A.3) for Luminal A vs. another class
were statistically significant (similarly for Luminal B). This is consistent with variation appearing
in an image individual component.
The positive end of individual component 2 picks out images with moderate cellularity and
collagenous stroma surrounded by moderate nuclear grade tumor cells.
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(a) (b)
Fig 15: Two tumors from the negative end of image individual component 2 both displaying muci-
nous carcinomas.
(a) (b)
Fig 16: Two tumors from the positive end of image individual component 2 both showing: collage-
nous stroma, moderate to high nuclear grade, moderate tumor cellularity.
The positive and negative ends of image individual component 2 show contrasting histologic
features. The patches from the tumors on the positive end are entirely filled with a combination of
tumor cell aggregates separated by areas of dense collagenous stroma. Adipocytic stroma is absent
and the only optically clear space is in areas of retraction artifact where tumor cell groups appear
to be pulled away from adjacent stroma (a known artifact of histologic preparation in some invasive
tumors). The patches from the negative end show extracellular mucin from mucinous carcinomas
with low or no tumor cellularity and just a few wispy bands of stromal collagen. The contrasting
histology raises the possibility that this component may separate tumors based on one or more of
the following features: tumor cellularity, tumor grade, extracellular stromal composition.
4.2.3. Image individual component 3. The negative end of image individual component 3 picks
up on tumors whose patches contain a large amount of optically clear space. This includes tumors
with: with high fat content (Figure 17b), where the cells discohesive (Figure 17c) and disrupted
tissue sections (Figure 17a). Recall (Section 2.2) that patches with too much background (over
90%) are removed. Therefore white space surrounding the tumors and large white spaces in the
core are unlikely to influence the amount of white space in the patches representing the image.
Some of the features seen in the images in Figure 17 17a and 17c are likely related to technical
variation in the tumor fixation/preservation and the quality of the histologic preparation. While the
high fat content pattern seen in the positive end of the first image individual component is similar
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to this component (i.e. it picks up on large amounts of white space) the first component uniformly
contains high fat content images in the top 15 images which is unlike this third component.
(a) Disrupted. (b) Fat cells. (c) Discohesion.
Fig 17: Three tumors from the negative end of image individual component 3 all showing the clear
visual pattern of a large amount of optically clear space.
(a) (b)
Fig 18: Two tumors from the positive end of image individual component 3. Both show a visually
clear pattern of dense collagenous stroma, low tumor cellularity, moderate nuclear grade, some
lymphocytes.
The positive end of this third component picks on images with a large amount of dense collagenous
stroma (Figure 18). This pattern is very clear in all 15 of the most positive subjects’ representative
images views (see Supplement A). These tumors have lower tumor cellularity, moderate nuclear
grade and have a moderate number of lymphocytes. Similar to the amount of white space, the
dense collagenous stroma is a clear visual pattern.
4.3. Genetic individual information. Figure 19a shows the PAM50 loadings vector of the first
genetic individual component. This component picks up on overall gene expression levels which
is a common source of technical variation. Both the second and third genetic individual compo-
nents show connections to the PAM50 subtypes based on the clinical data comparisons given in
Supplement A albeit with weaker separations than the joint components.
The second genetic individual component identifies additional information which varies between
Luminal A and Normal that is not dependent on cell proliferation and seems to be more related
to features such as estrogen receptor signaling and keratin expression status. The scores for this
second component separate Normal-like from Luminal A with an AUC of 0.801.
Figure 19b shows a scatter plot of the loadings vector from genetic individual component 2
compared to the Normal-Luminal A mean difference direction15. Several of the genes on the top
15The genes were first scaled by their standard deviation so this is the naive Bayes classification direction.
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left of 19b (ESR1, FOXA1, PGR) are all part of the estrogen signaling pathway (Oh et al., 2006).
Several of the genes in the middle (CCNB1, MYC, MKI67, TYMS, MYBL2, CCNE1) are related
to proliferation suggesting this component is unrelated to proliferation. Several of the genes in
the bottom right (KRT5, KRT14, KRT17) are characteristic of normal myoepithelium as well as
Basal-like like breast cancer (Lazard et al., 1993).
(a) Genetic individual component 1
loadings shows common genetic tech-
nical mode of variation not expected
to be associated with the images.
(b) Genetic individual component 2 loadings vector compared to
Normal-Luminal A mean difference direction. Luminal A is on
the left (negative) while Normal-like is on the right (positive).
Fig 19: Genetic individual components show technical variation as well as additional PAM50 subtype
information.
5. Conclusion. This paper develops methods that, using deep learning and AJIVE give in-
terpretable, simultaneous image and genetic results. Inferential and exploratory analysis leveraging
deep learning is a promising area which presents many interesting, open questions – some of which
are discussed below. These analytical tools enable simultaneous engagement from both the pathol-
ogy and genetic communities which is critical for the fundamental biomedical interpretations.
Future research should evaluate whether the features learned in this paper can be reproducibly
identified by pathologists and/or automated computer vision systems as well as whether these
features can be validated in external test sets.
Scaling histological image analysis pipelines to gigapixel whole slide images (WSI) is an important
future direction. In clinical practice, pathologists use WSIs; the core images used in this paper
require additional preparation, are typically only available in some research settings and may ignore
important tumor information (e.g. spatial heterogeneity across the tumor, particularly histological
patterns not observed in the sampled region). Analyses of WSIs presents computational challenges
as these images are orders of magnitude larger than the core images.
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5.0.1. Patch representation. Patch based approaches have shown promise for predictive tasks
using deep learning Ilse, Tomczak and Welling (2018). The patch based approach taken in this
paper was selected because it i) will scale to whole slide images ii) can identify localized image
information e.g. with the RPVs and iii) creates a smaller feature set16. The approach of averaging
of patch features ignores some within image heterogeneity. For image-only analysis, methods such as
Bishop and Tipping (1998); Backenroth et al. (2018) may be able to capture additional within-image
heterogeneity. In the context of multi-view data, additional methodology needs to be developed to
account for grouped observations (e.g. Pourzanjani et al. (2017)).
5.0.2. Transfer learning. Training a neural network can be time and resource intensive. Fur-
thermore, CNNs often require a large amount of training data to be fit effectively. Transfer learning
allows the data analyst to use more powerful neural networks with less data and less time spent
tuning CNN parameters (Yosinski et al., 2014; Sharif Razavian et al., 2014). First, a CNN is trained
to solve a different predictive task on a large, external dataset – typically the famous ImageNet
classification task (Deng et al., 2009). Then the pre-trained network parameters may be fine-tuned
on the dataset of interest to solve the predictive problem of interest.
The setting of this paper is a bit different. First, we are doing exploratory analysis, not predictive
analysis. Second, while we do have labels which could be used to fine-tune the CNN (e.g. the PAM50
subtypes) we do not want to use these labels because then the network would be aware of informa-
tion which we might want to (re)discover and/or validate in the following analysis. This leaves us
with a couple of options to still use transfer learning including: training an unsupervised algorithm
(e.g. auto-encoders Kingma and Welling (2013), generative adversarial networks Goodfellow et al.
(2014) or self-supervised learning algorithms Oord, Li and Vinyals (2018); Lu et al. (2019)) or not
doing any fine tuning. Ash et al. (2018) trains auto-encoder which has some disadvantages: a CNN
is required to be trained which is time/resource consuming, a number of new hyper-parameters are
introduced into the problem and either the data are used twice or external data are needed. We
explore the latter option and show, perhaps surprisingly, that pre-trained CNN features with no
fine tuning are able to capture complex visual signals in a domain vastly different than the one
they were originally trained on.
Even in the context of transfer learning, there are many choices to be made about how to
extract neural network features from an image including: network architecture, layer (or layers)
of the network, and feature aggregation (e.g. spatial mean pooling discussed in Section 2.3). For
predictive modeling these hyper-parameters can be set using an error metric and methods such as
cross-validation, however, as discussed in the above paragraph, we do not have such error metrics
readily available to guide hyper-parameter choices. Preliminary sensitivity analysis showed that
the results of our analysis are not particularly sensitive to mild differences in architecture choices.
Better methods to select these CNN hyper-parameters is an open area of research.
APPENDIX A: APPENDIX SECTION
A.1. Common tissue structures. Below we give examples of some of the tissue structures
which are relevant to this paper. Histopathology images are quite complex and pathologists are
trained for years to interpret them.17 For a more in-depth discussion of breast cancer pathology see
Rosen (2001); Schnitt and Collins (2009).
16Passing the full core images through the CNN resulted in 106 features.
17And pathologists don’t always agree with each other about their interpretations Elmore et al. (2015).
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(a) Lymphocytes (b) Tumor cells (c) Collagenous stroma (1)(d) Collagenous stroma (2)
(e) Fat cells (adipocytic
stroma)
(f) Mucin (g) Duct
Fig 20: Examples of some of the common histology structures discussed in this paper.
• Figure 20a shows tumor infiltrating lymphocytes (TILs), the nuclei of which are basophilic
(dark blue or purple) in conventional hematoxylin and eosin-stained (H&E) tissue sections.
Hematoxylin quantitatively stains nucleic acids (DNA and RNA). Stromal TILs are more
common in certain subtypes of breast cancer and may be associated with prognosis and
response to treatment.
• Figure 20b shows mostly high nuclear grade tumor cells (basophilic, dark blue or purple nuclei
on H&E) as well as some stroma (eosinophilic or pink on H&E). Nuclear grade describes how
abnormal the tumor cells look: “low grade” means the nuclei resemble those of normal cells
and “high grade” means the nuclei are enlarged, hyperchromatic (more basophilic, darker
blue/purple staining than normal nuclei), irregularly shaped and may contain multiple nu-
cleoli. Nucleoli are small intranuclear organelles that contain DNA, RNA and protein and
are responsible for the synthesis of ribosomes (ribosomes are the organelles that synthesize
proteins).
• Figure 20c shows collagenous stroma which is synthesized by fibroblasts and myofibroblasts
and appears as eosinophilic (pink) fibrillar extracellular material on H&E. Collagenous stroma
is the connective tissue that provides the scaffolding and support for epithelial structures. The
nuclei (basophilic, dark blue or purple on H&E) of a few fibroblasts are visible in a collagenous
stroma.
• Figure 20d shows clusters of tumor cells separated by areas or eosinophilic (pink) collagenous
stroma. On H&E-stained tissue sections, the tumor cell nuclei and their contents are basophilic
(blue/purple) and the tumor cell cytoplasm varies from pale to eosinophilic (pink). This is a
common histologic appearance of breast cancer as it invades into the stroma as aggregates or
sheets of tumor cells.
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• The large white spaces in Figure 20e are the cytoplasm of adipocytes, cells that synthesize
lipids (i.e, fat). The lipid-filled cytoplasm of adipocytes appears as these optically clear areas
because the solvents used in the routine preparation of H&E tissue sections dissolve the
lipids, leaving blank spaces where the lipids in the cytoplasm were. The ratio of fatty stoma
to collagenous or fibrous stroma varies with age. Older patients will have more fatty stroma
than younger patients. This age-related decrease in breast stromal density accounts for the
increased accuracy of mammography in older patients.
• Figure 20f shows extracellular mucin, a glycoprotein produced by epithelial cells which can be
present in both normal and tumor tissue. Mucin appears almost clear or pale pink or blue in
H&E-stained tissue sections. Invasive breast cancers with pure mucinous histology are often
low-grade and are thought to have a better prognosis than invasive ductal carcinoma of no
special type.
• Figure 20g shows a normal duct in the lower left and low cellularity invasive carcinoma in
the upper right part of the image. The benign cells contain nuclei that lack the enlargement,
irregular shape and multiple nucleoli often seen in tumor cell nuclei. The benign cells have
ample pale eosinophilic (pink) cytoplasm. The cells rest on a thin basement membrane which
appears as a circumferential eosinophilic (pink) band around the periphery of the duct. The
optically clear space in the middle of the duct is the lumen.
Remark A.1. There are a couple of terms important to this paper which are similar but have
different meanings. Clinical HER2 and molecular HER2 are two separate classifications used in
breast cancer; the former is a immunohistochemical classification used in the clinic to determine
clinical decision making while the latter is a genetic subtype. High nuclear grade refers to individual
cancer cells; high tumor grade is based on a composite index including nuclear grade, tubule for-
mation and mitotic activity. Collagenous stroma refers to (the pink) connective tissue; adipocytic
stroma refers to (the white) fat cells.
A.2. AJIVE diagnostics. The initial signal ranks are 81 (image features) and 30 (genes).
There were chosen by inspection of the the difference of the log-singular values and airing on the
side of picking too high a rank.
Note the Wedin bound does not provide any value for these data. This is likely due to known
conservativeness of the Wedin bound for non-square matrices. The random direction bound – which
can be seen to be equivalent to the classical Roy’s latent root test for CCA rank selection – estimates
the joint rank to be 7. This estimated joint rank was fairly robust to moderate changes in the
initial signal ranks. The image individual rank is estimated to be 76 and genetic individual rank is
estimated to be 25. These are likely overestimates, however, we focus only on the first few individual
components.
A.3. Clinical data interpretation methods. In addition to the H&E images and gene
expression data, we have a variety of clinical variables which can be used to interpret the different
AJIVE components (e.g. PAM50 subtype). We compare each clinical variable of interest with the
AJIVE scores for each component (i.e. the common normalized scores, image individual scores and
genetic individual scores).
For continuous variables (e.g. proliferation score) we create a scatter plot, report the Pearson
correlation and use the standard t-test test to determine if the association is statistically significant.
For example, Figure 5c shows the first joint component (x-axis) compared to the proliferation scores
(y-axis). The text in the top left reports the Pearson correlation and is bolded if the correlation is
statistically significant (after correction for multiple testing).
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Fig 21: The AJIVE diagnostic plot shows that 7 possible joint directions are closer together than
random. The vertical black/gray line segments show the principal angles between the X and Y
signal subspaces (on the squared singular value scale). The vertical, red, shaded bar shows the 5-
95th percentile of the distribution of leading principal angles between two random subspaces with
the same dimensions as X and Y . The dashed, vertical, red line shows the random direction cutoff.
The gray line segments correspond to angles larger than the cutoff while the black line segments
correspond to the angles smaller than the cutoff.
For categorical variables we show a conditional histogram of the scores and report difference in
distribution tests for each possible class comparison using the Mann Whitney U test. This test
test is used because it looks for location differences and because its test statistic is equivalent
to the AUC statistic which gives an interpretable measure of how well separated two classes are.
For categorical variables with more than 2 classes (e.g. there are five PAM50 subtypes) we do all
one-vs-one comparisons.
For example, Figure 5b shows the first joint component (x-axis) conditioned on PAM50 subtype.
The legend lists the classes, number of subjects in each class, and the the type of test. For a
given class, the legend lists the other classes which were statistically significantly separated (after
multiple testing adjustment) and reports the test statistics (AUC score) in parentheses. The class
name is bold if at least one other class is statistically significantly separated. For example, in Figure
5b molecular Her2 is statistically significantly separated from Basal (AUC = 0.876 ), Luminal A
(AUC = 0.897) and Normal (AUC = 0.827), but not Luminal B.
We compare each of the joint and individual AJIVE components to 33 variables. Additionally,
for each multi-class categorical variable we do all of the one vs. one tests (e.g. for 5 classes we do(
5
2
)
tests). Therefore adjustment for multiple testing is necessary to avoid spurious results. For each
of the AJIVE joint, image individual and genetic individual components we use the Benjamini-
Hochberg procedure Benjamini and Hochberg (1995) which is implemented in Statsmodels Seabold
and Perktold (2010).
Some of the clinical variables (e.g. proliferation scores, PAM50 molecular subtype) compared to
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the AJIVE scores are derived directly from the PAM50 gene expression which were used in the
AJIVE analysis. This raises issues related to post selection inference when we compute p-values for
these comparisons. Because the focus of this paper is on exploratory analysis we leave these issues
for follow up work.
All joint, image individual and genetic individual clinical data comparisons are shown provided
in Supplement A.
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